Summary
Stanford University is operating a virtual biotech with 37,000 AI agents, and one of its AI-designed drug candidates has been independently confirmed by Merck. This project, led by James Zou, demonstrates the potential of large-scale AI agent collaboration in scientific research, with agents even engaging in debates to produce more robust solutions.